Overview

Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja.

Status:
Unknown status

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

Summary

Postpartum haemorrhage is the leading cause of maternal haemorrhage globally. With active management of labour 3 to 16.5% of parturients still experience postpartum haemorrhage. Hence the need for an effective oxytocic in third stage of labour.

Phase:

Early Phase 1

Details

Lead Sponsor:

Lagos State University

Treatments:

Ascorbic Acid
Misoprostol
Vitamins